Preview

Medical and Biological Problems of Life Activity

Advanced search

Assessment of the quality of life of patients who have had COVID-19 infection, in mild and moderate forms

https://doi.org/10.58708/2074-2088.2023-1(29)-75-81

Abstract

The COVID-19 infection pandemic is characterized by high morbidity, unclear prognosis of complications and a decrease in the quality of life of patients. The article presents the results of a prospective single-center cohort study of the quality of life of 134 patients who suffered from COVID-19 infection in mild and moderate forms. 99 patients reported the presence of any disorders at the time of the survey, 35 patients reported the absence of problems. 53,7% of respondents were concerned about moderate pain and/or discomfort, 41,8% of patients experienced a feeling of anxiety and/or depression and moderate mobility disorders. The median for EQ-VAS in patients with no symptoms was significantly higher compared to the median for EQ-VAS in patients with any problems (80 points versus 65 points, respectively). After a COVID-19 infection, mild to moderate forms of pain and/or discomfort, anxiety and/or depression, impaired mobility are present in half of the subjects, which leads to a decrease in the quality of life of patients.

About the Authors

O. L. Nikiforova
УО «Гомельский государственный медицинский университет»
Belarus


N. V. Galinovskaya
УО «Гомельский государственный медицинский университет»
Belarus


E. V. Voropaev
УО «Гомельский государственный медицинский университет»
Belarus


References

1. World Health Organization. Coronavirus diseace (COVID-19) pandemic, 2022. [Electronic resource]. Global website of the world health organization. [date of access 2022 October 10]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus- 2019

2. JHU: Онлайн статистика по пациентам с COVID-19 Университета Johns Hopkins University. Режим доступа : https://coronavirus.jhu.edu/map.html Дата доступа - 10.10.2022.

3. Антонович, Ж.В. Длительный COVID и постковидный синдром как междисциплинарная проблема / Ж.В. Антонович // Рецепт. – 2022. – Т. 25(4). – С. 5-42. DOI: https://doi.org/10.34883/ PI2022.25.4.010

4. Post-COVID-19 syndrome / D. Montani [et al.] // Eur Respir Rev. 2022; 31(163):210185. DOI: 10.1183/16000617.0185-2021

5. Post-COVID-19 Syndrome / J.D. Pierce [et al.] // Nurs Res. – 2022. – Vol. 71(2). – P. 164-174. DOI: 10.1097/NNR.0000000000000565

6. Популяционные показатели качества жизни, связанного со здоровьем по опроснику EQ-5D / Е.А. Александрова [и др.] // Здравоохра- нение Российской Федерации. – 2018. – Т. 62(6). – С. 295-303. DOI: http://dx.doi.org/10.18821/0044- 197Х-2018-62-6-295-303

7. Mohammed, M.A. Pharmaceutical care and health related quality of life outcomes over the past 25 years: Have we measured dimensions that really matter? / M.A. Mohammed, R.J. Moles, T.F. Chen // Int J Clin Pharm. – 2018. – Vol. 40(1). – P. 3-14. DOI: 10.1007/s11096-017-0582-8

8. Новик, А.А. Руководство по исследова- нию качества жизни в медицине. 2-е издание / А.А. Новик, Т.И. Ионова, Под ред. Акад. РАМН Ю.Л. Шевченко. – М.: ЗАО «ОЛМА Медиа Групп», 2007. – 320 с. DOI: https://www.cpkmed.ru/materials/ El_Biblio/AktualDoc/osnovy-zdravoohranenija/5.pdf

9. A comparative review of generic qualityof- life instruments / S.J. Coons [et al.] // Pharmacoeconomics. – 2000. – Vol. 17(1). – P. 13-35. DOI: 10.2165/00019053-200017010-00002

10. Valuation of the EQ-5D-3L in Russia / V. Omelyanovskiy [et al.] // Qual Life Res. – 2021. – Vol. 30(7). – P. 1997-2007. DOI: 10.1007/s11136-021- 02804-6

11. Devlin, N.J. EQ-5D and the EuroQol Group: Past, Present and Future. / N.J. Devlin, R. Brooks // Appl Health Econ Health Policy. – 2017. – Vol. 15(2). – P. 127-137. DOI: 10.1007/s40258-017-0310-5

12. Post-Intensive Care Unit Syndrome in a Cohort of COVID-19 Survivors in New York City. / K. Weidman [et al.] // Ann Am Thorac Soc. – 2022. – Vol. 19(7). – P. 1158-1168. DOI: 10.1513/ AnnalsATS.202104-520OC

13. Post-Intensive Care Syndrome in Survivors from Critical Illness including COVID-19 Patients: A Narrative Review / C.S. Vrettou [et al.] // Life (Basel). – 2022. – Vol. 12(1). – P. 107. DOI: 10.3390/life12010107

14. Evaluation of health-related quality of life of Covid-19 patients: a hospital-based study in South Central Ethiopia / A.W. Kaso [et al.] // Health Qual Life Outcomes. – 2021. – Vol. 19(1). – P. 268. DOI: 10.1186/s12955-021-01900-y

15. Impact of long-COVID on health-related quality of life in Japanese COVID-19 patients / S. Tsuzuki [et al.] // Health Qual Life Outcomes. – 2022. – Vol. 20(1). – P. 125. DOI: 10.1186/s12955-022-02033-6

16. Health-Related Quality of Life and Its Socio- Demographic and Behavioural Correlates during the COVID-19 Pandemic in Estonia / M. Tamson [et al.] // Int J Environ Res Public Health. – 2022. – Vol. 19(15). – P. 9060. DOI: 10.3390/ijerph19159060

17. The impact of Post-COVID-Syndrome on functioning - results from a community survey in patients after mild and moderate SARS-CoV-2-infections in Germany / C. Lemhöfer [et al.] // J Occup Med Toxicol. – 2021. – Vol. 16(1). – P. 45. DOI: 10.1186/s12995- 021-00337-9

18. Андреев, Д.А. Базовые варианты анкеты EQ-5D – стандартные международные инструмен- ты оценки качества жизни. Краткий обзор литера- туры / Д.А. Андреев, А.А. Завьялов, А.Ю. Кашур- ников // Здоровье мегаполиса. – 2021. – Vol. 2(1). – P. 62-69. DOI: https://doi.org/10.47619/2713-2617. zm.2021.v2i1;62-69

19. Parallel Valuation of the EQ-5D-3L and EQ-5D-5L by Time Trade-Off in Hungary / F. Rencz [et al.] // Value Health. – 2020. – Vol. 23(9). – P. 1235- 1245. DOI: 10.1016/j.jval.2020.03.019

20. Амирджанова, В.Н. Валидация русской версии общего опросника EuroQol-5D (EQ-5D) / В.Н. Амирджанова, Ш.Ф. Эрдес // Научно-практи- ческая ревматология. – 2007. – Т. 45(3). – С. 69-76. DOI: https://doi.org/10.14412/1995-4484-2007-691


Review

For citations:


Nikiforova O.L., Galinovskaya N.V., Voropaev E.V. Assessment of the quality of life of patients who have had COVID-19 infection, in mild and moderate forms. Medical and Biological Problems of Life Activity. 2023;(1):75-81. (In Russ.) https://doi.org/10.58708/2074-2088.2023-1(29)-75-81

Views: 363


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2088 (Print)